Project Grant HT94252510918
- This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...
- The federal Project Grant award titled "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This $1,051,179 grant, awarded on September 15, 2025, supports research conducted by the Western Institute For Veterans Research (WIVR), a non-profit organization based in Salt Lake City, Utah. The...
- The Defense Health Agency awarded a $1.5 million Project Grant to the Western Institute For Veterans Research to support the POSITIONED (PRECISION, STANDARDIZATION AND ORGANIZATIONAL READINESS IN TBI CARE) program. This funding will support the Military Medical Research and Development program's goal of transforming health care for Service Members and the public through innovative medical research solutions for the battlefield. Specifically, the POSITIONED program will conduct research from...
- The Department of the Army Medical Command awarded a $777,315 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support the development of a novel noninvasive near-infrared light treatment for traumatic brain injury. Specifically, the University of Michigan will work to translate technology that uses specific infrared wavelengths to modulate mitochondrial function and limit reactive...
- The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...
- This $746,410 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the University of Utah supports research to investigate "Tissue Softening as a Biomarker of Traumatic Brain Injury." The award, effective from August 15, 2024 to August 14, 2027, will enable the university to conduct cutting-edge biomedical research aimed at developing improved diagnostic and treatment approaches for traumatic brain injury, a critical health...
- This federal Project Grant award of $4,981,294.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to Oregon Health & Science University (OHSU) for the project "LIGHT THERAPY TO IMPROVE SLEEP IN VETERANS WITH TBI: SLEEP-ACTIVE BIOMARKERS AND GLYMPHATIC FUNCTION". The award period runs from October 1, 2025 to September 30, 2029. The objective of this grant is to conduct advanced biomedical research aimed at...
- The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
- The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...
- This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
The U.S. Department of Defense's Defense Health Agency has awarded a $4,613,247 Project Grant titled "SHINING LIGHT ON TRAUMA: TREATMENT OF CHRONIC TBI TO IMPROVE PSYCHOLOGICAL HEALTH USING PHOTOBIOMODULATION IN SERVICE MEMBERS, VETERANS AND FIRST RESPONDERS" to the Western Institute For Veterans Research (WIVR), a non-profit organization in Salt Lake City, Utah. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will support research into developing innovative photobiomodulation treatments to address chronic traumatic brain injury and improve psychological health in service members, veterans, and first responders. The project will run from September 1, 2025 to October 31, 2029. WIVR will collaborate with academic partners, including the University of Texas Health Science Center at San Antonio, The Henry M. Jackson Foundation, University of Alabama at Birmingham, and University of Utah, to conduct this research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $4.6m | 8/20/25 |